Treatment Overview

Cholera is a severe and rapidly progressing bacterial infection that causes profuse, watery diarrhea. The onset can be frighteningly sudden, quickly leading to massive fluid and electrolyte loss. This rapid dehydration can quickly cause severe fatigue, muscle cramps, and dangerous drops in blood pressure, making it difficult for an affected individual to seek help or function normally. Without timely intervention, the condition can be life-threatening within hours, underscoring the urgency of effective treatment.

Treatment for cholera matters because it is almost entirely focused on replacing what the body loses, allowing the patient’s own immune system to clear the bacteria. The primary goal is to prevent shock and death due to severe dehydration. While antibiotics are used to shorten the illness, the most critical intervention is rapid fluid replacement. Medication choices, particularly the selection of antibiotics, depend on the severity of the illness and the specific Vibrio cholerae strain present in the affected area (Centers for Disease Control and Prevention, 2021).

Overview of treatment options for Cholera

The overall treatment strategy for cholera is twofold: immediate rehydration and, for severe cases, the use of antibiotics to target the underlying cause.

The main goal is to replace the fluids and salts lost through diarrhea and vomiting. This step is non-negotiable and life-saving. For patients experiencing mild to moderate symptoms, this means consuming large amounts of Oral Rehydration Solution (ORS). Patients with severe dehydration, indicated by signs like shock or inability to hold down fluids, require rapid intravenous (IV) fluid administration in a clinical setting. Medication, primarily in the form of antibiotics, plays a supportive role, reducing the overall severity and duration of the illness and minimizing the amount of bacteria shed into the environment.

Medications used for Cholera

While rehydration is the priority, antibiotics are used to treat the infection itself, shorten the illness, and reduce the patient’s contagiousness. Antibiotics are particularly recommended for severely dehydrated patients and those with other health conditions.

The primary drug classes used to target the Vibrio cholerae bacteria include Tetracyclines, Macrolides, and Fluoroquinolones. Doxycycline (a tetracycline) is widely used and is often a first-line agent, though it may be avoided in very young children. Azithromycin (a macrolide) is an excellent alternative, particularly in pregnant women and children. Fluoroquinolones, such as ciprofloxacin, may be used if local antibiotic resistance data suggests they are more effective.

Antibiotic treatment typically lasts only a few days. Patients can expect the most dramatic improvement immediately following successful rehydration. Diarrhea volume usually begins to decrease significantly within 24 to 48 hours after starting the appropriate antibiotic, reducing the total duration of the illness (World Health Organization, 2020).

How these medications work

The life-saving action of Oral Rehydration Solution (ORS) is elegant in its simplicity. Cholera toxin causes the intestines to dump massive amounts of water and electrolytes into the bowel. ORS contains glucose (sugar) and sodium (salt). This specific combination utilizes the natural sodium-glucose co-transport mechanism in the small intestine, forcing the body to absorb water alongside the dissolved salts, counteracting the effects of the toxin.

Antibiotics work by directly killing the Vibrio cholerae bacteria in the small intestine. This stops the bacteria from continually producing the cholera toxin, thereby reducing the amount of fluid secreted into the gut. By reducing the volume of diarrhea, antibiotics help the patient recover more quickly and minimize the risk of spreading the bacteria to others.

Side effects and safety considerations

Antibiotics carry standard risks, including gastrointestinal upset like nausea or vomiting. Doxycycline is known to increase sensitivity to the sun, requiring patients to use protective measures when outdoors. Fluoroquinolones are generally used with caution due to the rare risk of tendon damage, especially in older adults.

The most critical safety consideration is recognizing dehydration. If a person cannot tolerate oral fluids due to persistent vomiting or shows signs of severe dehydration (sunken eyes, extreme thirst, reduced urination, or shock), immediate medical care for IV fluid administration is necessary. Antibiotics should always be selected based on local resistance patterns to ensure effectiveness (Mayo Clinic, 2022).

Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. Centers for Disease Control and Prevention. https://www.cdc.gov
  2. World Health Organization. https://www.who.int
  3. Mayo Clinic. https://www.mayoclinic.org
  4. MedlinePlus. https://medlineplus.gov

Medications for Cholera

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Cholera.

Found 1 Approved Drug for Cholera

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin

Minocycline

Brand Names
ZILXI, Emrosi, Amzeeq, Arestin, Minocin
Form: Injection, Aerosol, Tablet, Powder, Capsule
Method of administration: Oral, Intravenous, Topical
FDA approval date: December 30, 1991
Classification: Tetracycline-class Drug
Minocycline hydrochloride tablets, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae. Lymphogranuloma venereum caused by Chlamydia trachomatis. Psittacosis (Ornithosis) due to Chlamydophila psittaci. Trachoma caused by Chlamydia trachomatis, although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis. Nongonococcal urethritis, endocervical, or rectal infections in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis. Relapsing fever due to Borrelia recurrentis. Chancroid caused by Haemophilus ducreyi. Plague due to Yersinia pestis. Tularemia due to Francisella tularensis. Cholera caused by Vibrio cholerae. Campylobacter fetus infections caused by Campylobacter fetus. Brucellosis due to Brucella species (in conjunction with streptomycin). Bartonellosis due to Bartonella bacilliformis. Granuloma inguinale caused by Klebsiella granulomatis. Minocycline is indicated for the treatment of infections caused by the following gram-negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Escherichia coli. Klebsiella aerogenes Shigella species. Acinetobacter species. Respiratory tract infections caused by Haemophilus influenzae. Respiratory tract and urinary tract infections caused by Klebsiella species. Minocycline hydrochloride tablets, USP are indicated for the treatment of infections caused by the following gram-positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug: Upper respiratory tract infections caused by Streptococcus pneumoniae. Skin and skin structure infections caused by Staphylococcus aureus. (NOTE: Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.) When penicillin is contraindicated, minocycline is an alternative drug in the treatment of the following infections: Uncomplicated urethritis in men due to Neisseria gonorrhoeae and for the treatment of other gonococcal infections. Infections in women caused by Neisseria gonorrhoeae. Syphilis caused by Treponema pallidum subspecies pallidum. Yaws caused by Treponema pallidum subspecies pertenue. Listeriosis due to Listeria monocytogenes. Anthrax due to Bacillus anthraci s. Vincent’s infection caused by Fusobacterium fusiforme. Actinomycosis caused by Actinomyces israelii. Infections caused by Clostridium species. In acute intestinal amebiasis, minocycline may be a useful adjunct to amebicides. In severe acne, minocycline may be useful adjunctive therapy. Oral minocycline is indicated in the treatment of asymptomatic carriers of Neisseria meningitidis to eliminate meningococci from the nasopharynx. In order to preserve the usefulness of minocycline in the treatment of asymptomatic meningococcal carriers, diagnostic laboratory procedures, including serotyping and susceptibility testing, should be performed to establish the carrier state and the correct treatment. It is recommended that the prophylactic use of minocycline be reserved for situations in which the risk of meningococcal meningitis is high. Oral minocycline is not indicated for the treatment of meningococcal infection. Although no controlled clinical efficacy studies have been conducted, limited clinical data show that oral minocycline hydrochloride has been used successfully in the treatment of infections caused by Mycobacterium marinum. To reduce the development of drug-resistant bacteria and maintain the effectiveness of minocycline hydrochloride tablets, USP and other antibacterial drugs, minocycline hydrochloride tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances